专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US06306908B1 Methods for reducing the incidence of necrotizing enterocolitis 有权
标题翻译：降低坏死性小肠结肠炎发病率的方法
公开(公告)号：US06306908B1
公开(公告)日：2001-10-23
申请号：US09570299
申请日：2000-05-12
申请人： Susan E. Carlson , Debra L. Ponder , Michael B. Montalto , Margaret H. Dohnalek , John D. Benson , David A. Borror , David V. Diodato
发明人： Susan E. Carlson , Debra L. Ponder , Michael B. Montalto , Margaret H. Dohnalek , John D. Benson , David A. Borror , David V. Diodato
IPC分类号： A61K31202
CPC分类号： A61K31/202
摘要： Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain &ohgr;-6 and &ohgr;-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.
摘要翻译：描述了含有基本上不含胆固醇的长链多不饱和脂肪酸（PUFA），例如花生四烯酸（AA）和二十二碳六烯酸（DHA））的肠内配方用于降低坏死性小肠结肠炎发病率的方法。来自蛋黄脂质的组合物是优选的，因为它们含有ω-6和ω-3长链PUFA并且主要是磷脂酰胆碱形式。这被认为是提供协同效应的。

2. 发明授权

US6080787A Methods for reducing the incidence of necrotizing enterocolitis 失效
标题翻译：降低坏死性小肠结肠炎发病率的方法
公开(公告)号：US6080787A
公开(公告)日：2000-06-27
申请号：US943576
申请日：1997-10-03
申请人： Susan E. Carlson , Debra L. Ponder , Michael B. Montalto , Margaret H. Dohnalek , John D. Benson , David A. Borror , David V. Diodato
发明人： Susan E. Carlson , Debra L. Ponder , Michael B. Montalto , Margaret H. Dohnalek , John D. Benson , David A. Borror , David V. Diodato
IPC分类号： A61K31/202 , A61K31/225 , A61K31/685
CPC分类号： A61K31/202
摘要： Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide .omega.-6 and .omega.-3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain .omega.-6 and .omega.-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.
摘要翻译：描述了含有基本上不含胆固醇的花生四烯酸（AA）和二十二碳六烯酸（DHA）的长链多不饱和脂肪酸（PUFA）的肠内配方。更具体地，本发明涉及通过施用提供ω-6和ω-3长链PUFA，磷脂和/或胆碱的组合物来降低坏死性小肠结肠炎的发生率的方法。目前优选蛋黄脂质的组合物，因为它们含有ω-6和ω-3长链PUFA，并且主要是磷脂酰胆碱形式。这被认为是提供协同效应的。

3. 发明授权

US06849268B2 Method for improving bone mineralization 失效
标题翻译：改善骨矿化的方法
公开(公告)号：US06849268B2
公开(公告)日：2005-02-01
申请号：US10639325
申请日：2003-08-12
申请人： John B. Lasekan , Marc L. Masor , Michael B. Montalto , John D. Benson
发明人： John B. Lasekan , Marc L. Masor , Michael B. Montalto , John D. Benson
IPC分类号： A23C9/152 , A23D9/007 , A23L1/29 , A23L1/30 , A23L1/304 , A61K31/20 , A61K31/201 , A61K31/23 , A61K33/06 , A61K36/18 , A61K36/28 , A61K36/48 , A61K36/899 , A61P19/00 , A61K47/00
CPC分类号： A61K31/23 , A23L33/12 , A23L33/16 , A23L33/40 , A61K33/06 , A61K2300/00
摘要： The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
摘要翻译：本发明涉及增加人类骨矿化的方法，更优选婴儿或幼儿。所述方法包括向所述人施用钙源和低棕榈酸的脂肪共混物。增强的矿化导致产生较高的峰值骨量，并相应降低骨质疏松症的发生率。

4. 发明授权

US06620427B2 Method for improving bone mineralization 失效
标题翻译：改善骨矿化的方法
公开(公告)号：US06620427B2
公开(公告)日：2003-09-16
申请号：US09876022
申请日：2001-06-08
申请人： John B. Lasekan , Marc L. Masor , Michael B. Montalto , John D. Benson
发明人： John B. Lasekan , Marc L. Masor , Michael B. Montalto , John D. Benson
IPC分类号： A61K4700
CPC分类号： A61K31/23 , A23L33/12 , A23L33/16 , A23L33/40 , A61K33/06 , A61K2300/00
摘要： The present invention is directed to a method for increasing the bone mineralization of a human, and more preferably an infant or toddler. The method comprises administering to said human a source of calcium and a fat blend that is low in palmitic acid. The enhanced mineralization results in the production of a higher peak bone mass and correspondingly lowers the incidence of osteoporosis.
摘要翻译：本发明涉及增加人类骨矿化的方法，更优选婴儿或幼儿。所述方法包括向所述人施用钙源和低棕榈酸的脂肪共混物。增强的矿化导致产生较高的峰值骨量，并相应降低骨质疏松症的发生率。

5. 发明授权

US06294206B1 Powdered human milk fortifier 有权
标题翻译：粉状人乳强化剂
公开(公告)号：US06294206B1
公开(公告)日：2001-09-25
申请号：US09532838
申请日：2000-03-21
申请人： Bridget Barrett-Reis , Patricia A. Reynolds , Michael B. Montalto , Deborah L. O'Connor
发明人： Bridget Barrett-Reis , Patricia A. Reynolds , Michael B. Montalto , Deborah L. O'Connor
IPC分类号： A23L1302
CPC分类号： A23C9/206 , A23C11/04 , Y10S426/801
摘要： The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder and a carbohydrate component present in a quantity of from about 15 wt/wt % to about 75 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.
摘要翻译：本发明涉及一种粉末状的人乳强化剂，其包含通常以强化剂粉末的约24重量/重量％至约55重量/重量％的量存在的蛋白质组分，和通常以约强化剂粉末的1重量％至约30重量/重量％和以强化剂粉末的约15重量％至约75重量％的量存在的碳水化合物组分。优选地，将粉末状的人乳强化剂设置在保持约0.5gm至约10gm粉末的单位剂量容器中。本发明还涉及通过向人乳添加强化剂粉末并将强化人乳给予早产儿来提供早产儿营养的方法。本发明还提供了一种通过向早产儿施用强化人乳来促进早产儿生长的方法。

6. 发明授权

US06472003B2 Powdered human milk fortifier 有权
标题翻译：粉状人乳强化剂
公开(公告)号：US06472003B2
公开(公告)日：2002-10-29
申请号：US09910094
申请日：2001-07-20
申请人： Bridget Barrett-Reis , Patricia A. Reynolds , Michael B. Montalto , Deborah L. O'Connor
发明人： Bridget Barrett-Reis , Patricia A. Reynolds , Michael B. Montalto , Deborah L. O'Connor
IPC分类号： A23L129
CPC分类号： A23C9/206 , A23C11/04 , Y10S426/801
摘要： The invention relates to a powdered human milk fortifier comprising a protein component typically present in an amount of from about 24 wt/wt % to about 55 wt/wt % of the fortifier powder, and a fat component typically present in an amount of from about 1 wt/wt % to about 30 wt/wt % of the fortifier powder and a carbohydrate component present in a quantity of from about 15 wt/wt % to about 75 wt/wt % of the fortifier powder. Preferably, the powdered human milk fortifier is provided in a unit dose container which holds from about 0.5 gm to about 10 gm of powder. The instant invention also relates to a method of providing nutrition to preterm infants by adding a fortifier powder to human milk and administering the fortified human milk to a premature infant. The invention further provides a method of promoting growth of a premature infant by administering fortified human milk to a premature infant.
摘要翻译：本发明涉及一种粉末状的人乳增强剂，其包含通常以强化剂粉末的约24重量/重量％至约55重量/重量％的量存在的蛋白质组分，和通常以约强化剂粉末的1重量％至约30重量/重量％和以强化剂粉末的约15重量％至约75重量％的量存在的碳水化合物组分。优选地，将粉末状的人乳强化剂设置在保持约0.5gm至约10gm粉末的单位剂量容器中。本发明还涉及通过向人乳添加强化剂粉末并将强化人乳给予早产儿来提供早产儿营养的方法。本发明还提供了一种通过向早产儿施用强化人乳来促进早产儿生长的方法。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式